It is a pharma private limited company based in Uttar Pradesh, Uttar Pradesh, India, established in 2001.
2001 | Uttar Pradesh, Uttar Pradesh, India | ActiveKant Drugs Private Limited, a active private limited company, was established on 05 February 2001 in Uttar Pradesh, Uttar Pradesh, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24232UP2001PTC025855. Registered under ROC Roc Kanpur. it is unlisted. It has an authorized capital of ₹5.00 Cr and a paid-up capital of ₹3.15 Cr.
It upholds a compliant status. Employing 57 professional, Its leadership includes Manoj Rastogi (Director), Mehul Rastogi (Director), Anurag Das (Director). Past directors included Manoj Rastogi, Kamini Rastogi, Vaibhav Rastogi. It holds ₹4.24 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Bharat Ashramraja Bazar Lucknow, Uttar Pradesh, Uttar Pradesh, 226003.
U24232UP2001PTC025855
025855
05 February 2001
₹5.00 Cr
₹3.15 Cr
Roc Kanpur
Unlisted
Active
Explore comprehensive insights into Kant Drugs Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Manoj Rastogi | Director | 05 Feb 2001 | Current |
| Mehul Rastogi | Director | 22 Sep 2015 | Current |
| Anurag Das | Director | 01 Mar 2010 | Current |
| Bharati Patwari Rastogi | Director | 18 May 2021 | Current |
| Aruna Das | Director | 05 Feb 2001 | Current |
| Kusha | Director | 05 Feb 2001 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Managing Director | 18 Jun 2009 | Past |
| Pramod Abcsdd | Director | 24 Apr 2021 | Past |
| Pramod Abcsdd | Director | 14 Sep 2009 | Past |
| Pramod Abcsdd | Director | - | Past |
| Pramod Abcsdd | Director | - | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Kant Drugs Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 12.11% increase. The company also saw a substantial improvement in profitability, with a 198.19% increase in profit. The company's net worth Soared by an impressive increase of 14.51%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2021, Kant Drugs had a promoter holding of 29.00% and a public holding of 71.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹42,400,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 27 Aug 2021 | Hdfc Bank Limited | ₹9.90 M | Open |
| 04 Jun 2016 | Hdfc Bank Limited | ₹3.25 Cr | Open |
Explore comprehensive loan charge details -
Kant Drugs has a workforce of 57 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Kant Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kant Drugs's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Kant Drugs Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
The activity Kant Drugs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Kanpur. was completed.
A charge with Hdfc Bank Limited of Rs. 3.25 Cr registered on 04 Jun 2016 with Charge ID 100035012 was modified on 13 Aug 2023. was recorded as a recent event.
The activity A charge with Hdfc Bank Limited amounted to Rs. 0.99 Cr with Charge ID 100475078 was registered on 27 Aug 2021. was completed.
Progress on Bharati Patwari Rastogi was appointed as a Director was appointed as a Director on 18 May 2021 & has been associated with this company since 4 years 6 months . was documented.
The activity A charge with Hdfc Bank Limited amounted to Rs. 3.25 Cr with Charge ID 100035012 was registered on 04 Jun 2016. was completed.
The CIN of Kant Drugs Private Limited is U24232UP2001PTC025855.
Kant Drugs Private Limited is headquartered at Bharat Ashramraja Bazar Lucknow, Uttar Pradesh, Uttar Pradesh, 226003.
Kant Drugs Private Limited was incorporated on 05 February 2001.
The current directors of Kant Drugs Private Limited are
The primary industry of Kant Drugs Private Limited is Manufacturing.
Kant Drugs Private Limited is unlisted.
The authorized capital of Kant Drugs Private Limited is ₹5.00 Cr, and the paid-up capital is ₹3.15 Cr.
The compliance status of Kant Drugs Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX